Trenbolone acetate

Veterinary uses In the livestock industry, trenbolone acetate is more often called Finaplix. It was intentionally developed to promote androgen and gain muscle mass in cattle. Due to its properties, this allows livestock to grow as much muscle as possible before they are transported to a slaughterhouse. Methyl cellulose and yellow dye are usually present in pellets given to livestock. A single dosage generally consists of ten pellets, and a package of Finaplix usually consists of one cartridge containing one hundred pellets. The medication is administered by subcutaneous injection into the posterior ear using an implanter gun. Finaplix is consistently implanted until the animal is ready to be slaughtered. There is no withholding period. Due to the common practice of trenbolone acetate use in veterinary medicine, it is quite common to find traces of trenbolone metabolites in cattle worldwide. Non-medical uses Bodybuilding Trenbolone acetate has never been approved for use in humans (but another ester of Trenbolone called Trenbolone hexahydrobenzylcarbonate was, for a short period of time under the name “Parabolan”, during the 1980’s, up until it’s discontinuation in 1997.) therefore guidelines for human consumption do not exist. Trenbolone hexahydrobenzylcarbonate was previously produced for human use by Negma Pharmaceuticals of France in 1.5 ml ampoules containing 76.5 mg of the steroid. ==Side effects==

Trenbolone acetate, like any other AAS, has many side effects. Its strong androgenic properties stimulate virilization, Common side effects include oily skin, acne, seborrhea, increased facial or body hair growth, and accelerated scalp hair loss. Cardiovascular Administration of any AAS can lead to cardiovascular issues. Trenbolone acetate can have a strongly negative impact on cholesterol levels by suppressing high-density lipoprotein (HDL) cholesterol production and stimulating low-density lipoprotein (LDL) cholesterol production. When compared to oral AAS, trenbolone acetate exerts a stronger negative effect on cholesterol levels. "Tren cough" The exact mechanisms underlying "tren cough" are not known; however, trenbolone acetate's androgenic effect activates a variety of lipid-like active compounds called prostaglandins, many of which are inflammatory and vasoconstrictive. Prostaglandins act on two signaling pathways: cyclooxygenase (COX) (also known as prostaglandin-endoperoxide synthase) and lipoxygenase (LOX) (EC 1.13.11.34, EC 1.13.11.33, etc.). The bradykinin peptide is well known to promote a cough reaction associated with ACE inhibitors prescribed for hypertension. Estrogenic and progestogenic Trenbolone is not estrogenic; may occur. ==Pharmacology==

Pharmacodynamics Trenbolone acetate is a prodrug of trenbolone. This is based on a book by William Llewellyn but has not been definitively proven. Trenbolone was never approved for human use, and therefore limited data on the subject exists. The relevant literature, is usually done in rats, which makes the 500/100 potency number inaccurate. Rats respond differently to androgens and are less sensitive to androgens. While some literature report a 5 fold higher potency, two other scientific reviews report a 3 fold higher potency, which makes it unclear as to how large the relative potency actually is. Trenbolone is an agonist of the progesterone receptor (PR), and in relation to this, has moderate to strong progestogenic activity. Similar to many other AAS, trenbolone acetate has the capability to produce insulin-like growth factor-1 (IGF-1). Trenbolone acetate also has the ability to increase red blood cell count. With a larger amount of red blood cells, blood oxygenation is enhanced. This allows for enhanced muscular endurance and therefore promotes a faster rate of recovery. Trenbolone acetate is capable of inhibiting glucocorticoids such as cortisol. The properties of glucocorticoid are the opposite of androgens as muscle tissue depletion and fat gain is promoted. Administration of trenbolone acetate aims at decreasing the production of glucocorticoid hormones. Trenbolone acetate’s contribution to feed efficiency, also known as nutrient efficiency is what makes it an attractive AAS used for agricultural purposes. Food is one of the most anabolic substances that any living organism can consume, and therefore with the administration of trenbolone acetate, every nutrient in the body becomes a lot more valuable. This facilitates an organism's body that is exposed to the AAS to make better use of the nutrients already consumed. Pharmacokinetics The acetate ester of trenbolone acetate allows for slow release post injection. This ester gives trenbolone an activated elimination half-life of about 3 days. ==Chemistry==

Trenbolone acetate, or trenbolone 17β-acetate, is a synthetic estrane steroid and a derivative of nandrolone (19-nortestosterone). It is the C17β acetate ester of trenbolone, which itself is δ9,11-19-nortestosterone (δ9,11-19-NT) or estra-4,9,11-trien-17β-ol-3-one. The structure of trenbolone acetate is a 19-nor classification, which represents a structural change of the testosterone hormone. Trenbolone acetate lacks a carbon atom at the 19 position and carries a double bond at carbons 9 and 11. The position of these carbons slows its metabolism, which greatly increases its binding affinity to the AR, and inhibits it from undergoing aromatization into the corresponding estrogenic metabolite. Trenbolone acetate contains trenbolone modified with the addition of a carboxylic acid ester (acetic acid) at the 17β-hydroxyl group. This facilitates the slow release of the AAS from the area of injection. ==History==

Trenbolone acetate was first synthesized in 1963 and approved by the livestock industry as a growth promoter for beef cattle in the early 1970s. During this period of its first administration, trenbolone acetate was sold under the names Finajet and Finaject. The original manufacturer of trenbolone acetate discontinued during the late 1980s and administered the synthesis of subcutaneous pellets called Finaplix. These pellets aimed to increase muscle mass and lean tissue of cattle prior to slaughter to increase the profitability of livestock when measured in total pounds of meat sold. The drug appears to have been an early development project of Roussel Uclaf, a French pharmaceutical company, and by the early 1970s, it was being sold as an injectable. There are a number of trenbolone esters but trenbolone acetate is the only one known to be produced in veterinary AAS manufacturers. Trenbolone acetate became popular among bodybuilders and athletes during the early 1980s. During this period, the AAS was transported illegally from Europe in large quantities. Although trenbolone acetate was very popular for a short amount of time, the large amounts of supplies were discontinued in 1987. This decision was based upon the public concern of sports doping and its negative effects on athletes. ==Society and culture==

Generic names Trenbolone acetate is the generic name of the drug and its , , and . Doping in sports Regardless of their legality, AAS are still banned by most sporting leagues in the country, who routinely conduct drug tests to find the users of any AAS. There are known cases of doping in sports with trenbolone acetate by professional athletes. == References ==